• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Hologic Inc.

    5/23/25 7:32:50 AM ET
    $HOLX
    Medical Electronics
    Health Care
    Get the next $HOLX alert in real time by email
    SD 1 a2025formsd-conflictminera.htm SD Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    __________________________________________________________ 
    FORM SD
     
     __________________________________________________________ 
    SPECIALIZED DISCLOSURE REPORT
     
     __________________________________________________________
    Hologic, Inc.
    (Exact name of registrant as specified in its charter)
     __________________________________________________________
    Delaware 1-36214 04-2902449
    (State or Other Jurisdiction of
    Incorporation or Organization)
     (Commission
    File Number)
     (I.R.S. Employer
    Identification No.)
    250 Campus Drive
    Marlborough, Massachusetts
     01752
    (Address of principal executive offices) (Zip Code)
    Karleen M. Oberton Telephone (508) 263-2900
    (Name and telephone number, including area code, of the person to contact in connection with this report)

     __________________________________________________________

    Check the appropriate box to indicate the rule pursuant to which this Form is being submitted, and provide the period to which the information in this Form applies:
     
    ýRule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.
    ☐
    Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended______________.



    SECTION 1 - Conflict Minerals Disclosure
    Items 1.01 and 1.02 Conflict Minerals Disclosure and Report, Exhibit
    A copy of Hologic, Inc.’s Conflict Minerals Report is provided as Exhibit 1.01 to this Form SD, and is publicly available at investors.hologic.com.
    The content of any website referred to in this Form SD, including any exhibit hereto, is included for general information only and is not incorporated by reference in this Form SD.
    SECTION 3 - Exhibits
    Item 3.01 Exhibits.
    Exhibit Number
      Description
    1.01
      Conflict Minerals Report of Hologic, Inc.



    Signatures
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
     
     HOLOGIC, INC.
    Date: May 23, 2025 By: /s/ Karleen M. Oberton
     Name: Karleen M. Oberton
     Title: Chief Financial Officer

    Get the next $HOLX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HOLX

    DatePrice TargetRatingAnalyst
    5/27/2025Hold
    Needham
    3/3/2025Buy → Hold
    Argus
    2/6/2025$80.00 → $75.00Outperform → Market Perform
    Leerink Partners
    2/3/2025Buy → Hold
    Needham
    12/13/2024Peer Perform
    Wolfe Research
    12/10/2024$90.00Buy
    Needham
    12/10/2024$85.00Hold
    Jefferies
    10/1/2024$95.00 → $85.00Buy → Neutral
    Citigroup
    More analyst ratings